Search

Author/Creator Finckh, A

21. THU0174 Drug retention of tofacitinib versus biologic antirheumatic agents in rheumatoid arthritis: observational data from the swiss scqm registry. (15th June 2017)

Authors:
Finckh, A; Herzog, L; Scherer, A; Dudler, J; Moeller, B; Ciurea, A; Mueller, R; Hasler, P; Exer, P; Muehlenen, I von; Kyburz, D; Gabay, C; Zufferey, P
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
267
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?. Issue 2 (4th May 2009)

Authors:
Finckh, A; Ciurea, A; Brulhart, L; Möller, B; Walker, U A; Courvoisier, D; Kyburz, D; Dudler, J; Gabay, C
Journal:
Annals of the rheumatic diseases
Issue:
Volume 69:Issue 2(2010)
Page Start:
387
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗